Gene · 10562
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative transcriptomic analysis of peripheral blood identifies NETosis-associated programs and a stratified adaptive immune suppression pattern in severe acute pancreatitis. | PLoS One | 2026 | 42789536 | PubTator, text mining | PubMed |
| Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis. | Comb Chem High Throughput Screen | 2026 | 42734237 | PubTator, text mining | PubMed |
| Incomplete Intestinal Metaplasia as a High-Risk Clinical Phenotype in Gastric Carcinogenesis: Implications for Surveillance and Management. | Digestion | 2026 | 42611800 | PubTator, text mining | PubMed |
| Novel insights into immunohistochemical analysis of intrahepatic cholangiocarcinoma: ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GalNAc1) as a new marker for large duct type. | Virchows Arch | 2026 | 42595919 | PubTator, text mining | PubMed |
| Neurovascular-Immune Biomarkers in Ménière Disease: Insights From High-Throughput Proteomics. | Otol Neurotol | 2026 | 42584982 | PubTator, text mining | PubMed |
| Identification of Biomarkers and Construction of Predictive Models for Sepsis and Septic Shock. | Clin Lab | 2026 | 42411682 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis Identifies an OLFM4-Associated Gastric Cancer Cell State with Palmitoylation-Related Signatures and Altered Metabolic Activities. | Biomolecules | 2026 | 42352346 | PubTator, text mining | PubMed |
| RUNX2 promotes chromatin accessibility and WNT signaling in inflamed intestinal epithelial cells. | Mucosal Immunol | 2026 | 42276192 | PubTator, text mining | PubMed |
| Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis. | Intensive Care Med Exp | 2026 | 42274989 | PubTator, text mining | PubMed |
| Tracing the stemness and malignant transition in a heritable colorectal cancer Lynch Syndrome by single-cell RNA-seq analysis. | Front Immunol | 2026 | 42266697 | PubTator, text mining | PubMed |
| Basal gland localization and focal distribution of OLFM4-expressing cells in increasing severity of gastric intestinal metaplasia. | bioRxiv | 2026 | 42239144 | PubTator, text mining | PubMed |
| [Research on 5-Fluorouracil-Induced Injury in Human Intestinal Organoids]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42227455 | PubTator, text mining | PubMed |
| Defining PI3K Signaling as a Key Regulator of Molecular Heterogeneity and Inflammation in Glomerular Lupus Nephritis. | Immune Netw | 2026 | 42109608 | PubTator, text mining | PubMed |
| Spatial transcriptomics defines IM-crypt as a premalignant niche with bidirectional divergence in early gastric carcinogenesis. | Commun Biol | 2026 | 42098407 | PubTator, text mining | PubMed |
| LRFN5 and OLFM4 in Acute Manic Episodes With Psychotic Features in Bipolar Disorder: A Case-Control Study in Türkiye. | Int J Psychiatry Med | 2026 | 42068214 | PubTator, text mining | PubMed |
| Immature Neutrophil Programs Associate With Burn Mortality and Extend Across Critical Illnesses. | J Burn Care Res | 2026 | 42053371 | PubTator, text mining | PubMed |
| NO- and S-nitrosothiols-dependent relaxation in large and small resistance blood vessels. | Front Physiol | 2026 | 42051746 | PubTator, text mining | PubMed |
| Olfactomedin 4 orchestrates TGF-β/CEACAM6 axis, promoting cell-autonomous epithelial to mesenchymal transition during gallbladder epithelium carcinogenesis. | Oncogene | 2026 | 42050078 | PubTator, text mining | PubMed |
| OLFM4 mediating ischemia/reperfusion-induced kidney injury by regulating renal tubular epithelial cells ferroptosis via GPX4. | Mol Biol Rep | 2026 | 42033502 | PubTator, text mining | PubMed |
| OLFM4 orchestrates the immunosuppressive microenvironment and drives gallbladder cancer progression. | J Cancer Res Clin Oncol | 2026 | 41934482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10562/papers